| Literature DB >> 34992467 |
Fenet Gemechu1, Mihret Ayalew2, Bereket Bahiru Tefera3, Temesgen Mulugeta4, Azmeraw Bekele5.
Abstract
BACKGROUND: The right to safe and effective treatment is an exclusive right that depends on the robustness of the domestic health care system.Entities:
Keywords: Addis Ababa; antiretroviral; inventory management
Year: 2021 PMID: 34992467 PMCID: PMC8710079 DOI: 10.2147/HIV.S337479
Source DB: PubMed Journal: HIV AIDS (Auckl) ISSN: 1179-1373
Figure 1Flow diagram showing document and health facility selection in public health facilities of Addis Ababa, January 2020.
Socio-Demographic Characteristics of Study Participants in Public Health Facilities of Addis Ababa, January 2020
| Variables | Hospital | Health Center | Total | |
|---|---|---|---|---|
| Educational level | Druggist | 0(0%) | 8(33.3%) | 8(18.2%) |
| First-degree pharmacist | 15(75%) | 16(66.6%) | 31(70.45%) | |
| Second-degree pharmacist | 5(25%) | 0(0%) | 5(11.4%) | |
| Working experience | 6 month–1 year | 1(5%) | 4(16.6%) | 5(11.36%) |
| 1–3 years | 3(15%) | 6(25%) | 9(20.45%) | |
| 3–5 years | 12(60%) | 12(50%) | 24(54.54%) | |
| >5 years | 4(20%) | 2(8.3%) | 6(13.6%) | |
| IPLS training | Received | 18(90%) | 18(75%) | 36(81.8%) |
| Not received | 2(10) | 6(25) | 8(18.18%) |
Availability and Updating Practice of Bin Cards in Public Health Facilities of Addis Ababa, January 2020 (N=22)
| Name of the Drug Product by Strength (mg) | Bin Card Available N (%) | Bin Card Updated N (%) |
|---|---|---|
| TDF+3TC+DTG(300+300+50) | 22(100) | 21(95.5) |
| TDF+3TC+EFV(300+300+600) | 22(100) | 20(90.91) |
| TDF+3TC(300+300) | 21(95.5) | 17(77.3) |
| AZT+3TC(300+150) | 22(100) | 17(77.3) |
| EFV 600 | 22(100) | 14(63.64) |
| ATV/R(300+100) | 20(90.91) | 11(50) |
| LPV/R(200 + 50) | 21(95.5) | 16(72.7) |
| AZT+3TC(60+30) | 20(90.91) | 17(77.3) |
| AZT+3TC+NVP(60+30+50) | 20(90.91) | 18(81.8) |
| EFV200 | 19(86.4) | 13(59.1) |
| EFV50 | 18(81.8) | 15(68.2) |
| NVP 10mg/mL | 20(90.91) | 16(72.7) |
| ATV/R(100+25) | 8(36.4) | 6(27.3) |
| LPV/R(80mL+20mL) | 20(90.91) | 18(81.8) |
| Average | 283(91.8) | 219(71.1) |
Availability of Antiretroviral Drugs in Public Health Facilities of Addis Ababa, January 2020 (N=22)
| Name of Drug Product | Availability of ARV Drugs | Total N (%) | |
|---|---|---|---|
| Hospitals N=10 (%) | Health Centers N=12 (%) | ||
| TDF+3TC+DTG(600+600+50) mg | 9(90) | 11(91.67) | 20(90.91) |
| TDF+3TC+EFV(600+600+600) mg | 9(90) | 11(91.67) | 20(90.91) |
| TDF+3TC(300+300) mg | 10(100) | 12(100) | 22(100) |
| AZT+3TC(300+150) mg | 9(90) | 12(100) | 21(95.45) |
| EFV 600 mg | 10(100) | 11(91.67) | 21(95.45) |
| ATV/R(300+100) mg | 6(60) | 9(75) | 15(68.18) |
| LPV/R(200 + 50) mg | 10(100) | 12(100) | 22(100) |
| AZT+3TC(60+30) mg | 8(80) | 12(100) | 20(90.91) |
| AZT+TCNVP(60+30+50) mg | 8(80) | 10(83.33) | 18(81.8) |
| EFV200 mg | 8(80) | 12(100) | 20(90.91) |
| EFV50 mg | 8(80) | 12(100) | 20(90.91) |
| NVP 10mg/mL | 9(90) | 11(91.67) | 20(90.91) |
| ATV/R(100+25) mg | 6(60) | 0(0) | 6(27.3) |
| LPV/R(80mL+20mL) | 10(100) | 12(100) | 22(100) |
| Average | 120(85.7) | 147(87.5) | 267(86.7) |
Figure 2Stock out duration of antiretroviral drugs in public health facilities of Addis Ababa, January 2020.
Figure 3Bin card accuracy of health facilities by drug type in public health facilities of Addis Ababa, January 2020.
Figure 4Data quality of RRF reports in public health facilities of Addis Ababa, January 2020.